Modified Double Wire Technique to Facilitate the Successful Cannulation

May 15, 2018 updated by: Yanglin Pan, Air Force Military Medical University, China

Modified Double Wire Technique to Facilitate the Successful Cannulation: Prospective Randomized Study

Selective cannulation is considered the most challenging step for most of Endoscopic retrograde cholangiopancreatography (ERCP). Wire-guided cannulation is the standard technique for initial cannulation. When meeting difficulty, double wire technique (DWT) is widely used. With one guidewire occupying pancreatic duct (PD), the following cannulation of common bile duct (CBD) with a sphincterotome preloaded with another guidewire often becomes feasible. However, because of the small opening of the papilla, sometimes it is technically challenging for the following cannulation of CBD with the sphincterotome and PD guidewire in the same working channel. We hypothesized that a tiny cut of the opening of papilla, without the injury of pancreatic sphincter, may facilitate the success of DWT and shorten the overall cannulation time.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shaanxi
      • Xi'an, Shaanxi, China, 710032
        • Recruiting
        • Endoscopic center, Xijing Hospital of Digestive Diseases
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 18-90 with native papilla;
  • CBD as the targeted duct;
  • Inadvertent PD cannulation more than twice;
  • Selective biliary cannulation was not possible within 10 minutes or 5 attempts.

Exclusion Criteria:

  • Contraindications of ERCP;
  • Major or minor PD as the targeted duct;
  • NK or transpancreatic precut before enrollment ;
  • Surgically altered GI anatomy;
  • Papillary carcinoma or stone impaction within papilla or fistula in papilla;
  • Prior endoscopic sphincterotomy;
  • Complete pancreas divisum;
  • failure of pancreatic duct cannulation;
  • Pregnant or breastfeeding women;
  • Unwilling or inability to provide consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Modified double wire technique
A sphincterotome was used for standard wire-guided cannulation. If the difficult biliary cannulation occurred and guidewire inadvertently entered PD, a tiny cut of opening, with the length of 5mm, was performed with the sphincterotome. Then the guidewire was left in PD and the sphincterotome withdrew. The same sphincterotome was re-inserted in the working channel alongside the first guidewire, another wire is used for wire-guided selective cannulation of CBD. If the cannulation of CBD was not successful within 5 attempts, other cannulation techniques (e.g. transpancreatic precut, needle knife (NK) precut or over-the stent precut) would be tried at the discretion of endoscopists. A 5Fr, unflanged PD stent was placed before the ending of ERCP.
For experimental arm, a tiny cut of papilla orifice, with the length of 5mm, was performed by sphincterotome before the double wire cannulation.
No Intervention: Standard double wire technique
A sphincterotome was used for standard wire-guided cannulation. If the difficult biliary cannulation occurred and guidewire inadvertently entered PD, the guidewire was left in PD and the sphincterotome withdrew. The same sphincterotome was re-inserted in the working channel alongside the first guidewire, another wire is used for wire-guided selective cannulation of CBD. If the cannulation of CBD was not successful within 5 attempts, other cannulation techniques (e.g. transpancreatic precut, NK precut or over-the stent precut) would be tried at the discretion of endoscopists. A 5Fr, unflanged PD stent was placed before the ending of ERCP.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success rate of double wire technique
Time Frame: 3 hours
the rate of successful cannulation of CBD for ≤5 attempts by using the sphincterotome alongside the PD guidewire.
3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cannulation time of double wire technique
Time Frame: 3 hours
the time taken from the touching of papilla by the sphincterotome alongside the PD guidewire to the successful cannulation of CBD
3 hours
Number of attempts for the successful CBD cannulation
Time Frame: 3 hours
3 hours
Overall cannulation success rate
Time Frame: 3 hours
3 hours
complication rates
Time Frame: 48 hours
48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2018

Primary Completion (Anticipated)

January 16, 2019

Study Completion (Anticipated)

February 16, 2019

Study Registration Dates

First Submitted

January 17, 2018

First Submitted That Met QC Criteria

January 22, 2018

First Posted (Actual)

January 29, 2018

Study Record Updates

Last Update Posted (Actual)

May 17, 2018

Last Update Submitted That Met QC Criteria

May 15, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • KY20180081-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endoscopic Retrograde Cholangiopancreatography

Clinical Trials on Modified double wire technique

Subscribe